The patients diagnosed with PD develop pathological changes, including a persistent reduction in dopaminergic neurons in the substantia nigra pars compacta, decreased dopamine levels in the striatum, and the formation of α-synuclein (αSyn) aggregates in the brain [96]. Here, SNCA is linked to Parkinson disease.